Whalen Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Whalen Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$493K	Buy	12,462 +725	+6%	+$25.9K	0.21%	115
2026 Q2	$398K	Sell	11,737 -743	-6%	-$24.7K	0.18%	136
2026 Q1	$376K	Sell	12,480 -1,333	-10%	-$42.9K	0.2%	132
2025 Q4	$431K	Sell	13,813 -11,643	-46%	-$287K	0.23%	129
2025 Q3	$514K	Buy	25,456 +10,659	+72%	+$187K	0.3%	76
2025 Q2	$248K	Sell	14,797 -11,495	-44%	-$185K	0.16%	178
2025 Q1	$404K	Buy	+26,292	New	+$470K	0.27%	85

Other funds holding TEVA

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CAM

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

VEM

Vann Equity Management Plano, Texas $168M AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Whalen Wealth Management's TEVA Position: Q3 2026 in Review

Whalen Wealth Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 6.2% in Q3 2026, buying an estimated $25.9K and bringing the position to 12,462 shares worth $493K. The position accounts for 0.21% of the portfolio, ranked #115.

Whalen Wealth Management first reported a position in TEVA in Q1 2025 and has held it in 7 quarters since. The position peaked at $514K in Q3 2025. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Whalen Wealth Management held 12,462 shares of Teva Pharmaceutical Industries Limited worth $493K as of Q3 2026.
Whalen Wealth Management bought 725 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $25.9K.
Teva Pharmaceutical Industries Limited made up 0.21% of Whalen Wealth Management's portfolio in Q3 2026, its #115 holding.
Whalen Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2025 and has held it in 7 quarters since.
Whalen Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $514K in Q3 2025.
10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Whalen Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.